Sunday, June 7, 2015

One in 30 children suffers from Braga “lazy eye” – TVI24

One in 30 children have revealed moderate to severe amblyopia during the first year of a screening project that disease, better known as “lazy eye”, held in Braga Hospital, was released today.

According to a hospital statement, Pimpolho Project runs from May 2014 and weekly serves about 30 children between three and four years old, to an ophthalmological consultation to prevent amblyopia.

“As part of the screening project of amblyopia in children of Braga, known pathology ‘lazy eye’, it is possible to conclude that one in 30 children have moderate to severe amblyopia,” the statement said .

When in doubt, children are flagged with a feedback that is sent to parents and guardians, through schools. Thus, if the situation deteriorate, parents should make appointments specialty.


The Pimpolho Project aims to outwit amblyopia all children of Braga, who attend public or private schools, aged three and four, ages at which the disease can be reversed .

The hospital stresses that amblyopia, if not treated, can affect “forever” to child health and life quality. Amblyopia is an exclusive disease of childhood and only treatable in this phase of life.

The hospital stresses even though the successful treatment of amblyopia can reach almost 100 per cent, while no treatment in pediatric causes blindness and low vision, low vision, not capable of being corrected for life. That is, even with subsequent surgery, optical correction or other treatment, the child will be “forever without normal vision.”

Amblyopia is reduced visual acuity of one or both eyes, caused by changes that disrupt the normal development of vision during a critical period. It is treatable up to 60 months, and its treatment less effective after that age.

The detailed assessment of the first year of Pimpolho Project will be made on Monday in conference press in Braga Hospital. The project is a partnership between the Hospital and the Braga Chamber.
 
                                                                                     

LikeTweet

No comments:

Post a Comment